Literature DB >> 11284727

Interaction of plasminogen with dipeptidyl peptidase IV initiates a signal transduction mechanism which regulates expression of matrix metalloproteinase-9 by prostate cancer cells.

M Gonzalez-Gronow1, H E Grenett, M R Weber, G Gawdi, S V Pizzo.   

Abstract

Both plasminogen (Pg) activation and matrix metalloproteinases (MMPs) are involved in the proteolytic degradation of extracellular matrix components, a requisite event for malignant cell metastasis. The highly invasive 1-LN human prostate tumour cell line synthesizes and secretes large amounts of Pg activators and MMPs. We demonstrate here that the Pg type 2 (Pg 2) receptor in these cells is composed primarily of the membrane glycoprotein dipeptidyl peptidase IV (DPP IV). Pg 2 has six glycoforms that differ in their sialic acid content. Only the highly sialylated Pg 2gamma, Pg 2delta and Pg 2epsilon glycoforms bind to DPP IV via their carbohydrate chains and induce a Ca(2+) signalling cascade; however, Pg 2epsilon alone is also able to significantly stimulate expression of MMP-9. We further demonstrate that the Pg-mediated invasive activity of 1-LN cells is dependent on the availability of Pg 2epsilon. This is the first demonstration of a direct association between the expression of MMP-9 and the Pg activation system.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11284727      PMCID: PMC1221751          DOI: 10.1042/0264-6021:3550397

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  63 in total

1.  The inhibition of receptor-mediated and voltage-dependent calcium entry by the antiproliferative L-651,582.

Authors:  D J Hupe; R Boltz; C J Cohen; J Felix; E Ham; D Miller; D Soderman; D Van Skiver
Journal:  J Biol Chem       Date:  1991-06-05       Impact factor: 5.157

2.  Serine phosphorylation of biosynthetic pro-urokinase from human tumor cells.

Authors:  M R Mastronicola; M P Stoppelli; A Migliaccio; F Auricchio; F Blasi
Journal:  FEBS Lett       Date:  1990-06-18       Impact factor: 4.124

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 4.  The plasminogen activation system in tumour invasion and metastasis.

Authors:  T J de Vries; G N van Muijen; D J Ruiter
Journal:  Pathol Res Pract       Date:  1996-07       Impact factor: 3.250

5.  The activation of type 1 and type 2 plasminogen by type I and type II tissue plasminogen activator.

Authors:  K Mori; R A Dwek; A K Downing; G Opdenakker; P M Rudd
Journal:  J Biol Chem       Date:  1995-02-17       Impact factor: 5.157

6.  Glu-plasminogen I and II: their activation by urokinase and streptokinase in the presence of fibrin and fibrinogen.

Authors:  Y Takada; Y Makino; A Takada
Journal:  Thromb Res       Date:  1985-08-01       Impact factor: 3.944

7.  Regulation and heteromeric structure of the fibroblast activation protein in normal and transformed cells of mesenchymal and neuroectodermal origin.

Authors:  W J Rettig; P Garin-Chesa; J H Healey; S L Su; H L Ozer; M Schwab; A P Albino; L J Old
Journal:  Cancer Res       Date:  1993-07-15       Impact factor: 12.701

8.  Proteolytic processing of the 72,000-Da type IV collagenase by urokinase plasminogen activator.

Authors:  J Keski-Oja; J Lohi; A Tuuttila; K Tryggvason; T Vartio
Journal:  Exp Cell Res       Date:  1992-10       Impact factor: 3.905

9.  Dipeptidylpeptidase IV activities are elevated in prostate cancers and adjacent benign hyperplastic glands.

Authors:  M J Wilson; A R Ruhland; B J Quast; P K Reddy; S L Ewing; A A Sinha
Journal:  J Androl       Date:  2000 Mar-Apr

Review 10.  CD26: a surface protease involved in T-cell activation.

Authors:  B Fleischer
Journal:  Immunol Today       Date:  1994-04
View more
  12 in total

1.  Towards the prophylactic and therapeutic use of human neutralizing monoclonal antibodies for Middle East respiratory syndrome coronavirus (MERS-CoV).

Authors:  Seiichi Sakamoto; Hiroyuki Tanaka; Satoshi Morimoto
Journal:  Ann Transl Med       Date:  2015-03

2.  A multi-center retrospective analysis of the effect of DPP4 inhibitors on progression-free survival in advanced airway and colorectal cancers.

Authors:  Azka Ali; Alejandra Fuentes; William Paul Skelton; Yu Wang; Susan McGorray; Chintan Shah; Rohit Bishnoi; Long H Dang; Nam H Dang
Journal:  Mol Clin Oncol       Date:  2018-11-13

3.  CD26/dipeptidyl peptidase IV regulates prostate cancer metastasis by degrading SDF-1/CXCL12.

Authors:  Yan-Xi Sun; Elisabeth A Pedersen; Yusuke Shiozawa; Aaron M Havens; Younghun Jung; Jingcheng Wang; Kenneth J Pienta; Russell S Taichman
Journal:  Clin Exp Metastasis       Date:  2008-06-18       Impact factor: 5.150

4.  Fibroblast activation protein α-positive pancreatic stellate cells promote the migration and invasion of pancreatic cancer by CXCL1-mediated Akt phosphorylation.

Authors:  Zhang Wen; Qiaofei Liu; Jihua Wu; Banghao Xu; Jilong Wang; Lizhou Liang; Ya Guo; Minhao Peng; Yupei Zhao; Quan Liao
Journal:  Ann Transl Med       Date:  2019-10

5.  Endothelial cell surface F1-F0 ATP synthase is active in ATP synthesis and is inhibited by angiostatin.

Authors:  T L Moser; D J Kenan; T A Ashley; J A Roy; M D Goodman; U K Misra; D J Cheek; S V Pizzo
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-29       Impact factor: 11.205

6.  CD26 expression on T cell lines increases SDF-1-alpha-mediated invasion.

Authors:  P A Havre; M Abe; Y Urasaki; K Ohnuma; C Morimoto; N H Dang
Journal:  Br J Cancer       Date:  2009-08-04       Impact factor: 7.640

7.  Mapping Salivary Proteases in Sjögren's Syndrome Patients Reveals Overexpression of Dipeptidyl Peptidase-4/CD26.

Authors:  Laís Garreto; Sébastien Charneau; Samuel Coelho Mandacaru; Otávio T Nóbrega; Flávia N Motta; Carla N de Araújo; Audrey C Tonet; Flávia M B Modesto; Lilian M Paula; Marcelo Valle de Sousa; Jaime M Santana; Ana Carolina Acevedo; Izabela M D Bastos
Journal:  Front Immunol       Date:  2021-06-17       Impact factor: 7.561

8.  Differential Expression and Enzymatic Activity of DPPIV/CD26 Affects Migration Ability of Cervical Carcinoma Cells.

Authors:  Aline Beckenkamp; Júlia Biz Willig; Danielle Bertodo Santana; Jéssica Nascimento; Juliano Domiraci Paccez; Luiz Fernando Zerbini; Alessandra Nejar Bruno; Diogo André Pilger; Márcia Rosângela Wink; Andréia Buffon
Journal:  PLoS One       Date:  2015-07-29       Impact factor: 3.240

Review 9.  CD26 and Asthma: a Comprehensive Review.

Authors:  Juan J Nieto-Fontarigo; Francisco J González-Barcala; Esther San José; Pilar Arias; Montserrat Nogueira; Francisco J Salgado
Journal:  Clin Rev Allergy Immunol       Date:  2019-04       Impact factor: 8.667

Review 10.  The Roles of Dipeptidyl Peptidase 4 (DPP4) and DPP4 Inhibitors in Different Lung Diseases: New Evidence.

Authors:  Tianli Zhang; Xiang Tong; Shijie Zhang; Dongguang Wang; Lian Wang; Qian Wang; Hong Fan
Journal:  Front Pharmacol       Date:  2021-12-09       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.